A Look Back at India’s Top IP Developments of 2023
SpicyIP
DECEMBER 30, 2023
Eventually, Johnson and Johnson announced that it would no longer enforce their patents for Bedaquiline (brand name: Sirturo) which is used in the treatment of multidrug-resistant tuberculosis (MDR-TB) in 134 low- and middle-income countries. The rejection order is authored by Dr. Latika Dawara, Asst. d) Other IP Developments 1.
124 
Let's personalize your content